Constitutive activation of STAT3 is causally linked to tumor development and progression in various types of solid malignancies, including head and neck cancer, myeloma, prostate cancer, breast cancer, colon cancer, and ovarian cancer [11–14]. This evidence concerns the gene STAT3 and ovarian carcinoma.